These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2613470)

  • 1. Phagocytic activity of polymorphonuclear leukocytes during haemodialysis in relation to some immunological findings.
    Kozioł M; Ksiazek A; Solski J; Rolla R; Rajtar B
    Int Urol Nephrol; 1989; 21(4):417-23. PubMed ID: 2613470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phagocytic function of neutrophils during dialysis in relation to some immunological findings.
    Ksiazek A; Kozioł M
    Nephrol Dial Transplant; 1991; 6 Suppl 3():31-4. PubMed ID: 1775264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute and chronic influence of hemodialysis according to the membrane used on phagocytic function of neutrophils and monocytes and pro-inflammatory cytokines production in chronic renal failure patients.
    Muniz-Junqueira MI; Braga Lopes C; Magalhães CA; Schleicher CC; Veiga JP
    Life Sci; 2005 Nov; 77(25):3141-55. PubMed ID: 16005905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phagocytosis activity of polymorphonuclear cells of normal persons and dialysis patients is influenced by different dialysis membranes.
    Schauer S; Stein G; Süss J; Falkenhagen D; Linss W
    Nephrol Dial Transplant; 1991; 6 Suppl 3():35-40. PubMed ID: 1775265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of hemodialysis with cuprophane and polysulfone membranes on counts of leukocytes, granulocytes, monocytes, lymphocytes and lymphocyte subsets].
    Moczulski D; Zukowska-Szczechowska E; Grzeszczak W; Religa Z; Cichoń R; Szydłowska I
    Pol Arch Med Wewn; 1994 Nov; 92(5):400-7. PubMed ID: 7885988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [C-reactive protein (CRP) as a marker of of hemodialysis biocompatibility].
    Szepietowski T; Krajewska M
    Polim Med; 1997; 27(1-2):47-59. PubMed ID: 9380601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement activation and C1q binding activity in haemodialysis.
    Dodd NJ; Vergani D; Turney JH; Parsons V; Weston MJ
    Proc Eur Dial Transplant Assoc; 1981; 18():300-4. PubMed ID: 6977138
    [No Abstract]   [Full Text] [Related]  

  • 8. Biocompatibility of dialysis membranes: effects of chronic complement activation.
    Hakim RM; Fearon DT; Lazarus JM
    Kidney Int; 1984 Aug; 26(2):194-200. PubMed ID: 6334194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Circulating immune complexes and neutrophilic phagocytic function in patients with idiopathic autoimmune thrombocytopenic purpura].
    Tishchenko LM; Volobueva ZV
    Vrach Delo; 1991 May; (5):80-3. PubMed ID: 1866927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunologic criteria of severity of suppurative infections in patients on programmed hemodialysis].
    Filiptsev PIa; Vetchinnikova ON; Anikina TP; Cherniakov VL
    Vestn Khir Im I I Grek; 1990 Jul; 145(7):98-100. PubMed ID: 2176418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increases in circulating level of platelet-activating factor lag behind transient neutropenia during hemodialysis with cuprophane membranes.
    Sakaguchi K; Morimoto S; Chen YH; Nakamoto Y; Ogihara T
    Nephron; 1991; 59(3):455-60. PubMed ID: 1758537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired phagocytosis in dialysis patients: studies on mechanisms.
    Alexiewicz JM; Smogorzewski M; Fadda GZ; Massry SG
    Am J Nephrol; 1991; 11(2):102-11. PubMed ID: 1951470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depressed phagocytosis in hemodialyzed patients: in vivo and in vitro mechanisms.
    Vanholder R; Dell'Aquila R; Jacobs V; Dhondt A; Veys N; Waterloss MA; Van Landschoot N; Van Biesen W; Ringoir S
    Nephron; 1993; 63(4):409-15. PubMed ID: 8459876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of recombinant human erythropoietin therapy on in vivo chemotaxis and in vitro phagocytosis of polymorphonuclear cells of hemodialysis patients.
    Sperschneider H; Neumann K; Ruffert K; Stein G
    Blood Purif; 1996; 14(2):157-64. PubMed ID: 8785031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. White blood count in patients on regular haemodialysis.
    Papadimitriou M; Baker LR; Seitanidis B; Sevitt LH; Kulatilake AE
    Br Med J; 1969 Oct; 4(5675):67-9. PubMed ID: 4898562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adhesion molecules in patients with chronic renal failure treated with haemodialysis].
    Musiał K; Zwolińska D
    Pol Merkur Lekarski; 2002 Sep; 13(75):177-81. PubMed ID: 12474564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in phagocytic activity of neutrophilic granulocytes during hemodialysis].
    Jarosíková T; Charvát J; Korcáková L; Holub M; Bláha J
    Vnitr Lek; 1985 Feb; 31(2):166-70. PubMed ID: 3984230
    [No Abstract]   [Full Text] [Related]  

  • 18. Dissociation between complement activation, integrin expression and neutropenia during hemodialysis.
    Rousseau Y; Carreno MP; Poignet JL; Kazatchkine MD; Haeffner-Cavaillon N
    Biomaterials; 1999 Oct; 20(20):1959-67. PubMed ID: 10514074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Phagocytic activity and oxygen radicals production of neutrophils in patients with chronic renal failure].
    Takahashi K; Imada A
    Nihon Jinzo Gakkai Shi; 1991 Jun; 33(6):565-74. PubMed ID: 1920936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dialyzer membrane type and reuse practice influence polymorphonuclear leukocyte function in hemodialysis patients.
    Rao M; Guo D; Jaber BL; Sundaram S; Cendoroglo M; King AJ; Pereira BJ; Balakrishnan VS;
    Kidney Int; 2004 Feb; 65(2):682-91. PubMed ID: 14717942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.